Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C
a study on Niemann-Pick Disease
Niemann-Pick Disease, Type C1 Pick Disease of the Brain Aphasia, Primary Progressive Frontotemporal Dementia Niemann-Pick Diseases Niemann-Pick Disease, Type A Niemann-Pick Disease, Type C Hydroxypropyl-β-cyclodextrin Hydroxypropyl-β-cyclodextrin IV
Lead Scientist at University of California Health
- Caroline Hastings, MD (ucsf)
Professor, Pediatrics. Authored (or co-authored) 7 research publications.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Cyclo Therapeutics, Inc.
- Phase 1
- Study Type
- Last Updated